|
WHO assesses significance of H1N1 virus mutation in Norway
GENEVA, Nov 20, 2009 (Xinhua via COMTEX) --
The World Health Organization (WHO)
said on Friday that it was assessing the public health
significance of a mutation of the pandemic H1N1 virus detected in
Norway and some other countries.
The Norwegian Institute of Public Health has informed the WHO
of a mutation of the H1N1 flu virus detected in two patients who
died and one with severe illness.
In addition to Norway, the mutation has also been observed in
Brazil, China, Japan, Mexico, Ukraine and the United States, with
the earliest detection occurring in April, the UN agency said in a
statement.
"The significance of the mutation is being assessed by
scientists in the WHO network of influenza laboratories," the
statement said.
"Although further investigation is underway, no evidence
currently suggests that these mutations are leading to an unusual
increase in the number of H1N1 infections or a greater number of
severe or fatal cases," it added.
According to the agency, the virus with this mutation remains
sensitive to the antiviral drugs, oseltamivir and zanamivir, and
studies show that currently available pandemic vaccines confer
protection.
In addition, the mutations appear to occur sporadically and
spontaneously. To date, no links between the small number of
patients infected with the mutated virus have been found and the
mutation does not appear to spread.
In a separate statement, the WHO said that the pandemic virus
has thus far caused at least 6,770 deaths worldwide, of which more
than 4,800 occurred in the Americas.
[ InfoTech Spotlight's Homepage ]
|